FDA panel rejects Pfizer’s arthritis drug as too risky

U.S. health advisers sharply criticized an experimental arthritis drug Thursday, saying that it was too risky, even with limits on its use. The expert panel for the Food and Drug Administration…

FDA warns Pfizer’s arthritis, colitis drug raises risk of heart issues and cancer

The Food and Drug Administration (FDA) on Thursday warned that early results from a safety trial on Pfizer’s arthritis and colitis drug, tofacitinib, revealed an increased risk of heart issues…

Seriously ill coronavirus patients in UK to receive rheumatoid arthritis drugs

U.K. government officials announced critically ill COVID-19 patients will soon receive rheumatoid arthritis drugs to boost recovery and odds of survival. The news comes amid approval of a third coronavirus vaccine…